Audrey’s Life Science Meeting Picks for October-November 2010 Complimentary Service of AudreysNetwork.com (Oct. 2, 2010 Edition)

*********************************************************** Bio2Device Group, Tuesday Morning, Oct. 5, 2010 Topic: “RoadMAP to Leadership – How to Develop and Train in a Small Biotech Environment” Speaker: Marco F. Rosa, Vice President of Human Resources, MAP Pharmaceuticals, Inc. Date and Time: Tuesday, Oct. 5, 2010, 8:30 – 10:30 am Location: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA (across the street from Sunnyvale Public Library) Cost: Free Street and in NOVA and library parking lots across the street.

Topic Description How do a small to medium sized /biotech/med-device companies infuse learning and development programs for key managers/directors and influence the executive team to fund this new program in light of cost constraints and budget cuts. How can HR make it happen and the by-product culminating in the Executive Team wanting to desperately join and be a “willing and instructional participant?”

Speaker Bio Mr. Rosa brings over 20 years of human resources experience and joined MAP Pharmaceuticals in May 2008 as Vice President of Human Resources. Prior, Mr. Rosa worked at Carl Zeiss Meditec, Inc. as Vice President of Worldwide Human Resources, a position he had held since May of 2002. He was an integral part of the senior management team overseeing the company's growth and the commercial launch of several ophthalmology and surgical microscopy devices. In addition, Mr. Rosa served as Vice President, Human Resources at COR Therapeutics, Inc. (Millennium Pharmaceuticals), building the development and commercial organization that launched Integrilin® into the cardiovascular angioplasty market. Before joining COR, Mr. Rosa held senior human resources and key senior administrative management positions with ReplayTV, Inc., Sony Electronics Inc. and the General Electric Company. In addition to his extensive human resources experience, Mr. Rosa served as a Captain in the BioMedical Corps (Search & Rescue Operations) of the United States Air Force. Mr. Rosa received his B.A. degree in Psychology from St. Michael's College and his M.A. degree in Counseling Psychology from New York University.

************************************************************** BayBio Summer Mixer, Wednesday Early Evening, Oct. 6, 2010

Event: BayBio Summer Blowout Mixer and Open House Date and Time: Wednesday, October 6, 4:00pm - 7:00pm Location: Pacific Research Center, 7777 Gateway Boulevard, Newark, CA Attire: Business Casual Cost: Complimentary See details for registration at www.BayBio.org. You must register on website to access. You can register as guest.

Event Description Join BayBio for its End of Summer Blowout Mixer at the Pacific Research Center, immediately off of Highway 84 and the Dumbarton Bridge in Newark. Barbecue and ice cream set the stage for this entertaining networking reception. Meet BayBio staff and vendors to learn more about cost-saving tips and BayBio Business Solutions. Leave with detailed insight into how BayBio can help your organization succeed and lower its bottom line using BayBio Business Solutions. The Pacific Research Center is a 10- building multi-tenant campus with 1.4 million square feet of laboratory, R&D and office space. Tours of the campus and laboratory suites at the Pacific Research Center will be offered by its owner, BioMed Realty Trust.

***************************************************************** Bioscience Business and Marketing Essentials, Thursday and Friday, Oct. 7-8, 2010

2-Day Intensive Course: Bioscience Business and Marketing Essentials, Thursday and Friday, Oct. 7-8, 2010 with 2 months to complete project Lead Instructor: Audrey S. Erbes, Ph.D., Principal, Erbes & Associates and www.audreysnetwork.com Expert Guest Speakers: . Donald Holsten, Pharm. D., Regulatory Consultant and Educator . Bev Hudson, MBA, Senior Vice President, Business Development, OmniComm Systems, Inc . Julie Tompkins, MBA, Senior Vice President, Timely Data Resources (TDR) Please see www.ucsc-extension.edu/BBME for details Date & Time: Oct. 7-8, 2010, Thursday and Friday, 8:30am-5pm Location: UCSC Extension in Silicon Valley, 2505 Augustine Drive, Santa Clara, CA 95053 Fee: $800

Topic Description The bioscience industry is like no other. Lengthy timelines and unique financial, legal, regulatory, social and political challenges impose constraints that impact every aspect of the business. This course helps participants gain: a practical understanding of the bioscience industry landscape, key business drivers and challenges; insight into the critical roles that business and marketing disciplines play at all stages of a bioscience company's development; and hands-on experience implementing important bioscience business processes that are essential to success within the industry. Two days of intensive classroom are followed by 2 months to complete individual project with guidance of instruction and access to research resources. For more information: See course listed under certificate program at www.ucsc-extension.edu/biobusiness.

Instructor:

Audrey Erbes, Ph.D., Principal, Erbes & Associates, is a marketing professional with more than 25 years of managerial experience in marketing and business development in the biotech and pharmaceutical industry. She is also a recognized speaker and industry blogger at www.audreysnetwork.com. She was Executive Vice President and cofounder of Kowa Research Institute, a biopharmaceutical licensing and investment subsidiary of Kowa Company Ltd., Japan. Prior to that, she held management positions at Syntex Corp. (acquired by Roche) in market research, product management, strategic marketing and planning, and business development in the U.S. and abroad, with a special emphasis on Europe and Asia/Pacific/Canada. Guest Speakers: Donald Holsten, Pharm D., a regulatory consultant and educator with over 20 years of national and international experience as a senior regulatory affairs and quality assurance executive, has expertise in food, drug/biopharmaceutical, medical device and cosmetic products. He has an intimate knowledge of the FDA approval cycle and has helped prepare numerous biotechnology and pharmaceutical companies for FDA interactions and panel reviews. Don has held management positions at several companies, including Liposome Technology, Inc and Oclassen Pharmaceuticals, Inc. where he was Director of Regulatory Affairs/Quality Assurance and Director of Regulatory Affairs, respectively. Earlier in his career he held a senior level position as Assistant Chief, Food and Drug Branch, Department of Health Services for the State of California. Topic: "Operating in the U.S. Regulatory Environment: Is Product Approvable."

Bev Hudson, M.B.A., is the senior vice president, Business Development, OmniComm Systems, Inc., a Web-based electronic data capture (EDC) and eClinical (eClinical) software and services company with products that streamline the clinical research process. Previously, she was VP and General Manager of Clinical Research Services at MedPoint Communications, Inc. and earlier ran sales and operations for Mayo Clinical Trial Services. She spent eleven years at Genentech in sales and marketing management roles. Topic: "The Impact of U.S. Health Care System on Marketing Biotech Products."

Julie Tompkins, M.B.A., is senior vice president at Timely Data Resources (TDR), a healthcare market research and consulting firm. She has nearly 30 years experience in the pharmaceutical and biotech arenas, including more than 12 years in industry and more than 20 years in market research consulting, and has worked with pharmaceuticals, diagnostics, and drug delivery systems. At Syntex (now Roche), Julie worked in both R&D and Marketing. After leaving Syntex, Julie was President and Founder of MedSearch, a primary market research company that merged with TDR in January 2000. Topic: "The Role of Market Research in Product Planning, Development and Marketing".

******************************************************************* NCC ACRP, Thursday Evening, Oct. 7, 2010

Event: East Bay Networking Event Date and Time: October 7, 2010, 5 PM – 9 PM No Registration Required Bring your business cards! Location: Skates on the Bay - Berkeley Marina, 600 Seawall Drive, Berkeley, CA 94710, (510) 549-1900

****************************************************************** MedTech Frontiers is a continuing series of free events for medical device and life science investors, entrepreneurs, clinicians, and technologists. Please join us for evenings of food, conversation, and presentations by Silicon Valley luminaries held on the first Thursday of each month. Events are free, but registration is requested for planning purposes - see the link below. A limited number of on-site registrations are available. If you received this invitation from a colleague, send a note to [email protected] to receive your own invitation and RSVP. All events start at 6pm and are held at

Medtech Frontiers, Thursday Evening, Oct 7, 2010

Topic: “The Bioartificial Kidney Project” Speaker: Dr. Roy, associate professor in the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the UCSF Schools of Pharmacy and Medicine, and director of the UCSF Biomedical Microdevices Laboratory Date and time: Thursday Evening, October 7, 2010 Location: Triple Ring Technologies, 39655 Eureka Dr., Newark, CA 94560. Cost: Free Register: Registration is requested for planning purposes. A limited number of on-site registrations are available. If you received this invitation from a colleague, send a note to [email protected] to receive your own invitation and RSVP.

Topic Description Dr. Roy will speak about the Implantable Bioartificial Kidney Project, which he leads. End-stage renal disease (ESRD) or chronic kidney failure affects 500,000 Americ and is increasing in prevalence at an annual rate of 5-7%. Dialysis is an expensive, short-term solution with a high mortality rate. Only 35% of patients remain alive after five years. Dialysis does not perform all of the functions of the natural kidney. Treatment of ESRD patients by transplant is hindered by the shortage of donor organs, while dialysis is expensive and confers significant morbidity and mortality. A bioartificial kidney has been developed by clinical collaborators at the University of Michigan, called the extracorporeal Renal Assist Device (RAD), that occupies an entire room and, like dialysis, the patient is tethered to the device. The UCSF Biomedical Microdevices Laboratory is using MEMS technology to miniaturize a bioartificial kidney that performs many of the functions of the natural kidney (beyond the filtering provided by dialysis alone) is surgically implanted into a patient, requires no tethers to machines outside the body, and requires no pumps or electrical devices to operate.

Speaker Bio Dr. Roy is an associate professor in the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the UCSF Schools of Pharmacy and Medicine, and director of the UCSF Biomedical Microdevices Laboratory. He holds the Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences II in the UCSF School of Pharmacy. Dr. Roy is also a founding member of the UCSF Pediatric Consortium, which has a mission to accelerate the development of innovative devices for children's health, and a faculty affiliate of the California Institute for Quantitative Biosciences. Before joining the BTS department in 2008, Dr. Roy co-directed the BioMEMS Laboratory in the Department of Biomedical Engineering at the Cleveland Clinic in Cleveland, OH. ******************************************************************* HBA, Thursday, Oct. 7, 2010

Topic: “Innovation Seminar-Beyond Eureka! Best Practices in facilitating the Innovation Process” Event Date and Time: Thursday October 7, 2010 Agenda: 5:00 – 5:30 PM Annual Business Meeting (Members Only) 5:30 – 6:00 PM Registration/Networking 6:00 – 6:15 PM Welcome/Opening Remarks 6:15 – 8:00 PM Program 8:00 – 8:30 PM Q&A/Closing Remark/Evaluations

Location: Bayer HealthCare Pharmaceuticals, 800 Dwight Way, Building 58, Berkeley, CA 94701,Phone: (510) 705-5059

Eligibility: Event is open to both HBA members and nonmembers

Registration Deadline: Onsite registration is allowed, online registration will remain open through the program date Topic Description: Too often innovation is characterized as a moment of “eureka!” Not only does this idea place undue pressure on individuals to innovate in an instant, it is also wrong. Innovation is a team process. This is not as easy as it sounds — there’s the fear of rejection, the need to want to be of value, and ego to be the one to solve the problem. Team innovation consists of four key roles: idea generators, idea connectors, implementers and diplomats. In this program you will learn what these roles mean, how to recognize them in your people, and how to harness the power of team innovation to lead your company to success.

Learning Objectives: 1. Learn best practices for innovation 2. How to implement innovation techniques with your projects and teams 3. How to lead teams through the innovation process 4. Develop the skill of facilitating the innovation process

NOTE: HBA San Francisco Bay Area members are also invited to attend the chapter’s Annual Business Meeting (ABM) which will begin at 5:00 PM (this is a members only session). During the ABM, members will review the key highlights and accomplishments of 2010, learn about upcoming plans for the 2011 calendar year and vote on officers and directors-at-large for the coming year.

***************************************************************** Bio2DeviceGroup, Tuesday Evening, Tuesday, Oct. 12, 2010

Topic: “Gene Therapy: The Next Generation Cancer Therapy” Speaker: Jeff Galvin, CEO, American Gene Technologies Date and Time: Tuesday Evening, Oct. 12, 2010 Location: Wilson Sonsini Goodrich & Rosati-- 650 Page Mill Road, Palo Alto , CA 94306 Register at www.bio2devicegroup.org week prior to meeting

Cost: $6 - Students/In-transition - Members only $11 - Early-bird Registration - Members only $20 - Late Registration and Non-Members $25 - Walk-ins

Topic Description Jeff will speak about the work of his company American Gene Technologies (AGTII) in developing potentially improved cancer therapies with higher efficacy than currently available drug treatments. AGTII was founded in 2007 to develop bio-safe, high- efficiency, multi-gene vectors for human gene delivery, in-vivo. AGTII’s products provide a method for the clinical delivery of gene therapy for the treatment of cancers, autosomal disorders, stem cell therapies, and cosmetic applications.

Speaker Bio Jeffrey A. Galvin, CEO, Inventor, and Co-Founder of AGTII earned his degree in economics from Harvard College in 1981. He has over 30 years of business and entrepreneurial experience in Silicon Valley including founder or executive positions at several startups that were taken public and/or sold to public companies -- including a company that provided the market-dominant quality control software for linear accelerators in cancer clinics which was sold to Varian, Inc (NYSE:VAR). In 2007 Mr. Galvin founded an angel investment company which provided the startup capital for AGTII.

******************************************************** Deloitte Recap’s Free Webinar, Tuesday Morning, Oct. 12, 2010

Topic: “Development and Commercialization Diligence in Biopharma Alliances” Join Recap's free, live webinar Date and Time: October 12, 2010,10:00-11:00 AM Pacific / 1:00-2:00 PM Eastern Register to attend today! http://www.recap.com/882575E5007F1AA1/w_WebinarReg?OpenForm&U=502ED6EA81 87E6CF88257752000BEBC1

Topic Description Is there more to development and commercialization diligence in biopharma alliances than "use reasonable efforts"? Should there be? Join us on October 12 to explore this issue. The business terms of biopharma alliances have changed substantially over the past decade with respect to financial payments, risk sharing and dev elopment options. However, the diligence standards for clinical development, regulatory approval and commercialization are generally unchanged when big pharma is the licensee, and only occasionally more specific when specialty pharma in-licenses a compound.

As more products come to market through alliances, should there be a tightening of performance requirements with respect to:

 Clinical development timetables  Development expenditures  Minimum annual sales  Commercial expenditures

We will survey recent biopharma alliances, describe and discuss novel approaches, and debate the merits and drawbacks of such provisions.

Who should attend:  Business development  Biopharma corporate executives  VCs and investment banks  CFOs and financial executives  Legal

Can't attend live? Register to receive the recorded webinar and accompanying slides. ******************************************************** SF AWIS, Wednesday Evening, Oct. 13, 2010

Event: “Social Networking” Date and Time: Wednesday, October 13th, 2010 Location: Bissap Baobab, 2323 Mission Street, San Francisco, COST: FREE All professionals in the sciences, students, and friends are welcome. For additional information check http://www.sfawis.com/

******************************************************************* NorCal BioPharmaPM, Thursday Evening, Oct. 14, 2010

Topic: "Perspectives on the Practice of Project Management in Biotechnology over the Last 15 years" Speakers: Rajendra Mohabir, Ph.D and Timothy Yang, PMP Date: Thursday October 14, 2010, 6:00-9:30 PM Location: Hilton Garden Inn MAP, 670 Gateway Boulevard, South San Francisco

Cost: $45 (+ nominal service fee), please RSVP on Eventbrite to register ************************************************************ Biotech Bay Career Fair, Monday Afternoon, Oct. 18, 2010

Date and Time: Monday, October 18, 2010, 2pm to 7pm Location: San Francisco Airport Marriott

Biotech * Pharmaceutical * Medical Device & Diagnostics To register go to http://www.biospace.com/jobs/career-fair-detail/?CareerFairId=202

Looking for a new job? Networking with industry peers in an ever-changing work environment? Attend the Biotech Bay Career Fair! Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Bay area.

Who should attend? Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. Just register by clicking the button below.

(Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

What types of positions are available? Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

What companies will be there? Scroll to the bottom of the pages to see a list of exhibiting companies. Take the time to research what each company is recruiting for to see if you are a match. Most companies will be from the Bay area, but some will travel from other regions to attract top talent! If you can’t make it on event day, you can still pre-register online to allow exhibiting companies to view your resume and contact you outside of the career fair. Want to hire candidates at this event? ****************************************************************

FountainBlue's Life Science Entrepreneurs' Forum, Monday Evening, Oct. 18, 2010

Topic: “Software Meets Healthcare: Forging the Win-for-All” Facilitator Soody Tronson, Soody Tronson Law Group

Panelist Melissa Karr, Vice President, Marketing, Brain Resource, Ltd Panelist Sunil Maulik, Board Adviser, Health 2.0; Senior VP, Business Development, People Power Company Panelist John Steuart, Managing Director, Claremont Creek VenturesPresenting Entrepreneur Ash Damle, Founder and CEO, Medgle

Date & Time: Monday, October 18 from 5:30 to 7:30 p.m.

Location: UCSC Extension, 2505 Augustine, Santa Clara

Member Registration: $22, through http://fountainblue.shuttlepod.org/ by September 24 at noon

Partner and General Registration: $32 - $42, through October 15 at noon using the PayPal link at http://www.svlifescience.com.

On-Site Registration Cost: $42 members, $52 non-members, $124 Ongoing membership plus admission

Audience: Life Science entrepreneurs, intrapreneurs and investors; no service providers please

Speaker Bios Soody Tronson, principal and founder of Soody Tronson Law Group, is a seasoned professional with over 20 years of experience combining law, science, engineering, and business management in start-ups and established environments. Soody practiced law as IP Counsel at Silicon Valley offices of prominent national law firms and in-house at the Hewlett-Packard Company. Soody was General Counsel and Vice President of Intellectual Property at a successfully acquired medical device start up company where she was responsible for all legal matters including clinical trials, corporate transactions (e.g., acquisition, merger), licensing and partnering transactions, employment issues; and played a key role in the development of strategies for dispute resolution and litigation. Before starting her legal career, she spent several years in the industry holding technical and management positions at companies such as Hewlett-Packard and Schering-Plough. Her extensive experience enables the patent and transactional counseling of clients in the areas of life sciences, medical devices, and high technology. Based on the range of her experience and founder of two companies, she is well accustomed to challenges facing emerging as well as mature companies. Soody serves in Of Counsel capacity with other firms and consults with several companies. She is on the advisory board of several organizations including, the Silicon Valley Chapter of the Licensing Executives Society (LES) and the Association for the Sports and Athlete Professionals. She instructs courses in IP and licensing at the University of California. She serves as a mentor at the Stanford Technology Venture Formation Program, is an advisor with Astia, and volunteers her services at local non- profit organizations. She is also an inventor on patent applications and issued patents. Soody holds a J.D. and M.S.; and is licensed to practice before the State of California and the U.S. Patent and Trademark Office.

Melissa Karr has extensive international advertising and marketing experience, and integrates customer insights, brand strategy and marketing communications skills in her role as VP of Marketing for Brain Resource, Ltd. Brain Resource has established the first and largest human brain database to make sense of the brain's complexities and provide a coherent model for measuring brain health. Prior to joining Brain Resource, Mrs. Karr served as account management with Young and Rubicam Advertising in the US and Europe, the Executive Director for the American Chamber of Commerce in Vietnam and as a marketing consultant to numerous life sciences start-ups. She received a BS in Marketing from Miami University and an MBA from Wayne State University.

Dr. Sunil Maulik has over twenty years of sales and business development experience in Silicon Valley. He has co-founded three companies, including MonetaSuite, a business analytics company focused on email activity; RemakeHealth, a healthcare-IT company; and GeneEd, a provider of e-learning solutions. In addition, he has held senior sales and management positions at Pangea Systems, Tripos, Hoffmann-La Roche, Oxford Molecular and IntelliGenetics. Sunil also participates in several non-profit ventures dedicated to improving health in sustainable communities, including Health2.0, the Pacific AIDS Education Center and Project Ahimsa. He is enthralled by the opportunity to create energy-sustainable communities by encouraging people to go green.

John has spent the last 20 years managing, building and investing in technology and life science companies. John focuses on the intersection of the information technology and life sciences markets including bioinformatics, molecular diagnostics, genomics, proteomics, software and instrumentation for med-tech industries. John serves on the board of directors of Arcxis, Tibion, Fluxion, Gene Security Network and Wired Benefits. He is an Industry Fellow at the Center for Entrepreneurship and Technology at the College of Engineering as well as a member of the Advisory Council to the Lester Center's Berkeley Entrepreneurs' Forum at UC Berkeley. Early in his career, he joined Alafi Capital, an Emeryville-based venture firm specializing in early-stage biomedical companies, where he served as an officer of the General Partner. At Alafi, John lead investments in more than a dozen successful start-ups, and served as the senior executive and board member of various firms such as Tanox, Software Ventures, Lipomatrix and Megan Health. In the mid-90s, together with colleague Nat Goldhaber, John helped start Cybergold, an Internet marketing and payments company, serving as the early COO and CFO through its IPO, merger with Mypoints and sale to United Airlines. John continued with the Mypoints unit of United serving as the Senior Vice President of Strategic Partnerships.

John lives in Berkeley with his wife and three children, a block away from the Triple Rock brewery. Throughout his career, Ash Damle has applied practical artificial intelligence (AI) with his work at MIT, Navy, California Department of Corrections and Rehabilitation, and Jcrew. Now, as founder and CEO of Medgle, Ash believes that the information revolution has changed the very fabric of society and is positioning Medgle to address the next stage of the i-revolution by facilitating the democratization of knowledge and expertise by empowering healers with the data and resources to better support their patients, and patients to better support themselves.

******************************************************************* Bio2Device Group, Tuesday Morning, Oct. 19, 2010

Topic: “New Frontiers for Aerosol Development: The Pulmonary Infusion Pump” Speaker: James B. Fink, PhD, RRT, FAARC, FCCP, Chief Clinical Officer, LLC Consultant, Scientific Advisor Aerogen, Adj. Prof. Georia State Univ. Date and Time: Tuesday, Oct. 19, 2010, 8:30 – 10:30 am Location: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA (across the street from Sunnyvale Public Library) Cost: Free Street and in NOVA and library parking lots across the street.

Speaker Bio Dr. Fink is a Registered Respiratory Therapist with Neonatal Pediatric Specialty Certification with the National Board for Respiratory Care, with a PhD in Pharmaceutical Innovation from Bradford University, UK and a Fellow of both the American Association of Respiratory Care (FAARC) and the College of Chest Physicians (FCCP). Jim was Director of Respiratory Programs at Aerogen in 2000, with 30+ years of experience in clinical and academic respiratory care as a clinician, manager, administrator, educator and researcher. As Fellow of Aerosol Science with Aerogen (and later Nektar), Jim was key to the development of high efficiency aerosol delivery systems for use with adults, children and infants in both critical care and ambulatory settings, with multiple US and international patents. Jim was Technical Director of Respiratory Care at University of California, San Francisco for 14 years and developed a medical aerosol research lab emphasizing aerosol delivery to critically ill patients at Hines VA Hospital and Loyola Stritch School of Medicine, Chicago. Jim is an internationally recognized researcher and lecturer authoring 3 textbooks, >40 chapters and >70 peer reviewed papers. Jim is currently an Adjunct Professor for the Respiratory Therapy Program at GA State University and serves on the editorial board for the Journal of Aerosol Medicine and Pulmonary Drug Delivery and the Board of Director for the International Society of Aerosol Medicine. Since 2003, Jim has worked as the primary interface with the Measles Aerosol Vaccine initiative of the WHO, and is actively involved in developing liquid aerosol delivery systems for mass campaigns in the third world.

************************************************************* Bioscience Forum, Wednesday Evening, Oct. 20, 2010

Speaker: Donald Francis, M.D., D.Sc, Executive Director, Global Solutions for Infectious Diseases "Vaccines for Less Developed Country Diseases: A New Era for Discovery and Development" Date and Time: Wednesday, October 20, 2010 6:00 PM - 9:00 PM 6:00 pm - 7 pm networking 7:00 pm - 8 pm dinner 8:00 pm - 9 pm presentation Location: The Clarion Hotel, 401 East Millbrae Avenue, Millbrae Full info and Registration at: http://biosf.org/ Cost: $45 before 9:00 PM, Monday, Oct. 18 $55 on-site $35 full-time students pre-registration $45 full-time students on-site $3 service fees will be added to the pre-registration prices Pre-Registration ends Monday, Oct. 18, at 9 pm Cash or check accepted on the day of the event Parking is $2 Review Event Summary and Register at: http://www.cvent.com/EVENTS/Info/Summary.aspx?i=a3314109-a5c4-40c7-a7d5- 8fef6ebe362b Cash or check accepted on the day of the eventParking is $2 Or you can pay with a check made out to "BioScience Forum" and sent to: BioScience Forum 1442A Walnut Street, #308 Berkeley, CA 94709-1405 Please do not mail checks later than Thursday, October 14th If paying with check, do not complete online registration with Cvent

Topic Description Vaccines, the predominant tool used to prevent worldwide infectious diseases, are a challenge to develop and bring to market. Recent funding from large not-for-profit institutions has stimulated a new era in vaccine development – especially for less developed country diseases. The funding has produced a new wave of vaccine discovery, actual product development and, ultimately, delivery to at-risk children. Not only have the children in less developed countries been the recipient of these vaccines, but more and more of both the development and manufacture of these important products is taking place outside of Europe and North America. BiographyAs an infectious disease trained pediatrician and epidemiologist, Dr. Francis has over 30 years experience in epidemic control and vaccines. He spent 21 years working for the U.S. Centers for Disease Control (CDC) focusing on vaccine-preventable diseases such as measles, cholera, smallpox, and hepatitis B. He directed the WHO’s Smallpox Eradication Program in Sudan and U.P. State in Northern India. His hepatitis B vaccine work included Phase III trials among gay men in the United States and among infants born to carrier mothers in China. Dr. Francis was also a member of the WHO team investigating the world’s first outbreak of Ebola virus in 1976.

Speaker Bio Dr. Francis has worked on HIV/AIDS since its emergence in 1981. He initially directed the AIDS laboratory at the CDC and worked closely with the Institut Pasteur to identify the causative virus. His early efforts to call attention to the threat of AIDS and warn of the inadequacy of the public health response were chronicled in the movie And the Band Played On. In 1992, he joined Genentech to spend full time developing vaccines, while he also helped found what became the International AIDS Vaccine Initiative (IAVI). With waning private sector interest in HIV vaccine development, Dr. Francis co-founded VaxGen, which completed the world’s first Phase III trials of two candidate HIV vaccines in 2003. In early 2004, he left VaxGen to co-found GSID with Carter Lee and Phil Berman.

**************************************************************** BayBio Therapeutic Focus, Thursday Early Evening, Oct. 21, 2010

Topic: “Therapeutic Focus | Drug and Biomarker Developments: The Evolution of Blockbusters?” Speakers: Panel Moderator: Michael J. Shuster, PhD, Partner, Fenwick & West LLP; Panel Speaker: Rowan Chapman, Partner, Mohr Davidow Ventures and Mitch Raponi PhD, Sr. Director Molecular Diagnostics, Clovis Oncology Date and Time: Thursday, October 21, 2010 Registration Opens: 3:30pm Panel Presentation: 4:00pm - 5:30pm Networking Reception: 5:30pm - 6:30pm Location: South San Francisco Conference Center, 255 South Airport Blvd., South San Francisco, CA Pre-registration through October 19 $20 BayBio Members | $40 Non-Members On-site registration on October 21 $40 BayBio Members | $75 Non-Members Attire: Business attire suggested See details for registration at www.BayBio.org. You must register on website to access. You can register as guest.

Topic Description The promise of personalized medicine has begun to be realized with several commercially successful products, notably Herceptin, Gleevec, and Rituxan that all rival conventional "blockbusters." Higher rates of efficacy and more efficient (and therefore cost effective) trials have made products based on biomarkers increasingly intriguing and attractive to an industry chronically beset with R&D failures. Should we expect life science and pharma companies to embrace the biomarker strategy as their primary business model, or will biomarker-derived products remain a niche market? And should diagnostics be developed in tandem with pharmaceuticals or independently? A panel of experienced industry executives will focus on the real world experiences and will provide valuable insight into business and regulatory landscape surrounding biomarker technology. ************************************************************** 2010 RAPS Annual Conference & Exhibition in San Jose, Sunday – Wednesday, Oct. 24-27, 2010

Topic: “Succeed in the Global Regulatory Environment” Dates: Sunday-Wednesday, Oct. 24-27, 2010 Location: San Jose McEnery Convention Center, San Jose, CA Find full details at http://www.raps.org/personifyebusiness/ Event Description Don’t miss the most globally representative conference RAPS has ever convened. Attendees will hear from more than 50 top officials from regulatory agencies around the world, including: . US Food and Drug Administration (FDA) . US Department of Justice (DOJ) . European Medicines Agency (EMA) . State Food and Drug Administration (SFDA), China . Pharmaceuticals and Medical Devices Agency (PMDA), Japan . Ministry of Health, Labour and Welfare (MHLW), Japan . Korea Food and Drug Administration (KFDA) . National Health Surveillance Agency (Anvisa), Brazil . Department of Biotechnology, Ministry of Science and Technology, India . Ministry of Health, Welfare and Sport, The Netherlands . Health Canada Fee: RAPS Member $1,230; nonmember $1,415. Thursday, 30 September is the last day to register for at the special advance rate (save $150) on your full conference registration! See details about special rates at http://www.raps.org/PersonifyEbusiness/Default.aspx?TabId=1604

******************************************************************* RAPS Conference Exhibitor Reception, Monday Evening, Oct. 25, 2010 Event: Exhibitor Reception and Wine Tasting at RAPS 2010

Date and Time: 25 October 2010, 5:00–6:00 pm Location: San Jose McEnery Convention Center,Santa Jose, CA Cost: $25 Even if you are unable to participate in the RAPS Annual Conference & Exhibition from Oct. 24-27 this year, RAPS, the SF Chapter invites you to attend the Exhibitor Reception and Wine Tasting on Monday, 25 October, from 5:00–6:00 pm, a special $25 rate. This special event pass includes:  Exclusive access to a premier networking event at 2010 RAPS, to include regulatory professionals and thought leaders from around the world as well as representatives from more than 100 companies on the leading edge of technology  One free drink ticket  Full access to the wine tasting, featuring a selection of wines from Napa Valley and Sonoma County accompanied by an assortment of cheese; William Hill and Louis Martini wineries will be represented Register at http://www.raps.org/personifyebusiness/tabid/55/Default.aspx?ProductId=6713 ******************************************************************* Windhover PharmAsia Summit 2010, Monday and Tuesday, Oct. 25-26, 2010

Topic: Taking the Risk Out of Asia: Top Pharma Leaders Share Best Practices-- the most strategic-level meeting where senior biotech and pharma executives share real-life case studies on how they're building a presence in Asia - from drug development to market. Date and Time: October 25-26, 2010 Location: InterContinental Mark Hopkins, San Francisco www.windhover.com/PharmAsiaSummit Cost: $200 Discount until September 30, 2010 Full Price after September 30, 2010 Standard Registration: 1st and 2nd attendee* $1495 ($200 savings) Includes:  Entrance to all sessions.  Admission to cocktail receptions and all breakfasts/lunches/breaks.  Conference materials, proceedings booklet, and copies of presentation slides, as permitted. 15% off any Elsevier Business Intelligence products purchased at the event. Dealmaker’s Package: 1st and 2nd attendee* $1995 ($350 savings) Includes:  2 nights hotel room & taxes and Recordings of sessions in addition to standard registration included *3rd free - Attendee provides hotel accommodation Early Bird Registration Ends Sept. 30th so register today! Convenient online registration is available http://www.windhover.com/windhover/content/conferences/pasreg.htm?&utm_campaig n=PAS10 or contact Pat Cardone at [email protected] or 203.838.4401x124.

Topic Description This year's PharmAsia Summit brings Asian, US and European industry leaders to San Francisco to share their experiences and help those already involved in Asian operations or planning Asia strategies to better understand the myriad of complex challenges and equally attractive opportunities facing them. Here's what you get from this year's PharmAsia Summit:  Merck's emerging markets strategy through acquisition vs. organic growth  5+ opinions on where to place your bets and how to hedge risks when investing in Asia  38+ perspectives from Asia investors, corporate executives and regulators  4+ regulator presentations from US, China, and Korea FDA  11+ networking opportunities with the most senior level executives  Lessons learned on how to overcome marketing authorization, pricing and market access issues when commercializing your drug in Asia Further details on top speakers and topics can be found online at www.windhover.com/PharmAsiaSummit.

*************************************************************** Bio2Device Group, Tuesday Morning, Oct. 26, 2010

Topic: A Clairvoyante Speaks: Electronic Communication in the Health Care Arena Speaker: Candice Brown Elliott, CEO and Chief Technologist, Nouvoyance Date and Time: Tuesday, Oct. 19, 2010, 8:30 – 10:30 am Location: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA (across the street from Sunnyvale Public Library) Cost: Free Street and in NOVA and library parking lots across the street.

Speaker Bio Candice Brown Elliott is an internationally recognized leader, entrepreneur, manager, and technologist/inventor in the flat panel display and microelectronic industries. She is a featured business leader on 50Lessons.com. She is a regularly invited speaker at international conferences, industry symposia, and universities. She has held engineering and managerial posts in leading semiconductor firms as well as start-up ventures. She has founded several technology companies and led industry research consortia programs. She has 50 issued US patents, with many more pending. She has a dual degree in physics and psychology, and minored in biology. Like so many other entrepreneurs, she is a drop-out from Stanford University Graduate School. In her over thirty five year career, she has served in nearly every capacity from Department Secretary up to CEO / Chairman of the Board.

*************************************************************** San Jose Biocenter, Thursday Mid-Day, Oct. 28, 2010

Topic: “Startup in a Box: Efficient Operations Management” Speakers Brian Hassan, Managing Director, BAYPOINT BENEFITS Justin Roberts, Managing Director, BAYPOINT BENEFITS Olga Karobkoff, CEO (Interim CFO for Start-ups), ACCUSTART Date and Time: Thursday, October 28, 2010, 11:30am-1:00pm Agenda 11:30am-12:00pm: Registration & Networking 12:00pm-1:00pm: Presentation and Q&A Location: San Jose BioCenter, 5941 Optical Court, Second Floor. San Jose, CA 95138 Cost: Regular Price: $25 • Partners' Network: $15 • BioCenter Members: Free (please RSVP to Melissa) • On-site Registration: add $10 to the above. This event is typically sold out, so early pre-registration is recommended to avoid disappointment on the day! Register at http://startupinaboxsjbc.eventbrite.com/ Topic Description With increased pressure to deliver value efficiently and effectively, startups need all the help they can get. Accurate, comprehensive operational management from the start is a crucial first step to the success of any business. Join us for one hour interactive session on how you can best manage your operations resulting in maximum time spent on value creation and minimum time spent on maintaining the back-end. In this session, you will learn the key steps to ensure every facet of your new business runs smoothly from finance, accounting, HR, legal/contracts, facilities management, general administration, and more. Who Should Attend:  Founders/entrepreneurs raising funding  Newly founded corporation overwhelmed with operational requirements  Rapidly growing young company looking for direction and assistance but isn't ready for a CFO  A business in need of a capital lease line or banking/cash management options  A small business requiring short-term support such as budget planning, audit preparation, finding office space, or preparation for lay-offs  A foreign company establishing an office in the U.S. ************************************************************* Bio2Device Group, Tuesday Morning, Nov. 2, 2010

Topic: TBA Speaker: TBA Date and Time: Tuesday, Nov. 2, 2010, 8:30 – 10:30 am Location: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA (across the street from Sunnyvale Public Library) Cost: Free Street and in NOVA and library parking lots across the street.

******************************************************************* Bio2Device Group, Tuesday Evening, Nov. 9, 2010

Topic: “Overcoming Challenges Common to Biotech Start-Ups” Speaker: Lubna Ahmad, PhD, Founder & CEO, Invoy Technologies Location: Wilson Sonsini Goodrich & Rosati-- 650 Page Mill Road, Palo Alto , CA 94306 Register at www.bio2devicegroup.org week prior to meeting Cost: $6 - Students/In-transition - Members only $11 - Early-bird Registration - Members only $20 - Late Registration and Non-Members $25 - Walk-ins

Topic Description This presentation will describe challenges associated with early stage medical device companies, including implementing a quality system, obtaining investment capital, fostering in-house innovation, and recruiting a management team.

Speaker Bio Lubna Ahmad, PhD, Founder & CEO, Invoy Technologies, LLC (www.invoy.com). Dr. Ahmad has spent nearly a decade innovating and developing medical devices with an emphasis on biosensor technologies. She founded Invoy to commercialize and build upon her novel designs. Having recruited an experienced and diversified team and raising necessary investment capital, Dr. Ahmad has managed the company through the development phase, executed a series of partnerships and intellectual property transactions, and positioned the company for product launch. Her experiences in sensor development and clinical study protocol design have been key in Invoy’s ability to successfully execute a demanding product development program. Dr. Ahmad also serves as an advisor to a molecular diagnostics company and is a frequent presenter at biotechnology seminars and conferences. Prior to founding Invoy, Dr. Ahmad was a fellow of the National Science Foundation. Dr. Ahmad holds a PhD in biomedical engineering from Arizona State University where she was a Goldwater Scholar. *********************************************************** FountainBlue's Life Science Entrepreneurs' Forum, Monday Evening, Nov. 15, 2010

Topic: “Personalized Medicine, Biomarkers, Invitro Diagnostics: The Science Advances, The Business Opportunities, The Cultural Dilemmas” Date & Time: Monday, November 15 from 5:30 - 7:30 p.m. Location: Life Technologies, 850 Lincoln Centre Drive in Foster City Pre-register: $21 members, $32 partners, $42 general Late and On-Site: $42 members, $52 non-members, $124 Ongoing membership and admission Members can register at: http://fountainblue.shuttlepod.org/lifescience To Become a Member visit: http://fountainblue.shuttlepod.org/membershipapp Non-Members and Partners can register at: http://www.svlifescience.com Pre-registration Deadline: November 12 at noon

Facilitator tbd Panelist from Life Technologies, to be confirmed Panelist VC, tbd Panelist from Stanford, tbd Panelist Brandon Steele, Vice President, Commercial Operations, IncellDx, Inc. Presenting Entrepreneur Robert E. Dunkle, President and CEO, PlexPress Inc. Presenting Entrepreneur, Biomarker Presenting Entrepreneur, Invitro Diagnostics Presenting Entrepreneur, Customized Treatments Audience: Life Science entrepreneurs, intrapreneurs and investors, no service providers please For more information, visit http://www.SVLifeScience.com.

******************************************************************* Bioscience Business Development: Building Value, Thursday & Friday, Dec. 2-3, 2010

Event Topic: Bioscience Business Development: Building Value Intensive Course Sponsoring Group: UCSC Extension Date and time: Thursday and Friday, Dec. 2-3, 2010 Location: 2505 Augustine Drive, Santa Clara, CA 95053 Speaker (s):  Instructors: Audrey Erbes, Principal, Erbes & Associates and www.audreysnetwork.com and and Gilbert R. Mintz, Ph.D., President of GRM Associates  Harold (Hal) Etterman, MBA, Business Strategist  Carolyn Feamster, MBA, VP, Business Strategy & Analysis  Ginger R. Dreger, M.S.,J.D., Partner Arnold & Porter LLP  Tom Gutshall, Chairman & Co-Founder of Cepheid  Guest speaker, Recombinant Capital  Herwig VonMorze, Ph.D., International Patent Consultant

Fees: $850.00, ($765 through Nov. 18) Registration and more Information: www.ucsc-extension.edu/biobizdev

Topic Description UCSC Extension in Silicon Valley presents a two-day intensive course that brings the breadth of the Bay Area’s biobusiness development expertise to our Santa Clara classroom. Whether financing start-up activities, trying to keep pace with the current burn rate, or moving a product into the marketplace, bioscience companies, both large and small, have a critical need for business development at every stage of their evolution. Learn the key roles that business development and licensing play in the commercialization of a new product and the development of a successful bioscience company. Santa Clara, CA. For more information, see www.ucsc-extension.edu/biobizdev *******************************************************************